Two Sigma Securities’s Matinas BioPharma MTNB Stock Holding History

Two Sigma Securities’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-837	Closed	-$23.7K	–	1828
2025 Q3	$23.7K	Buy	+837	New	+$18K	﹤0.01%	1109
2025 Q2	–	Sell	-1,398	Closed	-$10.9K	–	1875
2025 Q1	$10.9K	Buy	+1,398	New	+$12.4K	﹤0.01%	1219
2024 Q1	–	Sell	-25	Closed	-$4.13K	–	3399
2023 Q4	$4.13K	Buy	+25	New	+$4.23K	﹤0.01%	2899
2022 Q1	–	Sell	-49	Closed	-$37K	–	2364
2021 Q4	$37K	Sell	49 -48	-49%	-$38.5K	﹤0.01%	1321
2021 Q3	$94K	Buy	+97	New	+$62.8K	﹤0.01%	1326
2021 Q2	–	Sell	-109	Closed	-$86K	–	1632
2021 Q1	$86K	Buy	+109	New	+$110K	﹤0.01%	705
2020 Q2	–	Sell	-14	Closed	-$6K	–	1595
2020 Q1	$6K	Buy	+14	New	+$12.7K	﹤0.01%	1257
2018 Q1	–	Sell	-20	Closed	-$18K	–	2851
2017 Q4	$18K	Buy	20 +3	+18%	+$2.89K	﹤0.01%	1635
2017 Q3	$16K	Sell	17 -11	-39%	-$11K	﹤0.01%	842
2017 Q2	$35K	Buy	+28	New	+$56.4K	0.01%	740

Other funds holding MTNB

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

HIW

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Two Sigma Securities's MTNB Position: Q4 2025 in Review

Two Sigma Securities sold out of Matinas BioPharma (MTNB) in Q4 2025, closing a stake of 837 shares — an estimated $23.7K sold.

Two Sigma Securities first reported a position in MTNB in Q2 2017 and held it in 10 quarters. The position peaked at $94K in Q3 2021. 28 funds tracked by Wall St. Rank hold MTNB as of Q4 2025.

Two Sigma Securities reported no remaining Matinas BioPharma position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 837 Matinas BioPharma shares in Q4 2025, an estimated $23.7K.
Two Sigma Securities first reported a position in Matinas BioPharma in Q2 2017 and held it in 10 quarters.
Two Sigma Securities's Matinas BioPharma position peaked at $94K in Q3 2021.
28 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.